376 related articles for article (PubMed ID: 27187696)
21. Derangement of the endothelial glycocalyx in sepsis.
Iba T; Levy JH
J Thromb Haemost; 2019 Feb; 17(2):283-294. PubMed ID: 30582882
[TBL] [Abstract][Full Text] [Related]
22. Endothelial Glycocalyx and Cardiopulmonary Bypass.
Myers GJ; Wegner J
J Extra Corpor Technol; 2017 Sep; 49(3):174-181. PubMed ID: 28979041
[TBL] [Abstract][Full Text] [Related]
23. The glycocalyx and calcium dynamics in endothelial cells.
Mortazavi CM; Hoyt JM; Patel A; Chignalia AZ
Curr Top Membr; 2023; 91():21-41. PubMed ID: 37080679
[TBL] [Abstract][Full Text] [Related]
24. Glycocalyx Degradation in Ischemia-Reperfusion Injury.
Abassi Z; Armaly Z; Heyman SN
Am J Pathol; 2020 Apr; 190(4):752-767. PubMed ID: 32035883
[TBL] [Abstract][Full Text] [Related]
25. Exocytosis of Endothelial Lysosome-Related Organelles Hair-Triggers a Patchy Loss of Glycocalyx at the Onset of Sepsis.
Zullo JA; Fan J; Azar TT; Yen W; Zeng M; Chen J; Ratliff BB; Song J; Tarbell JM; Goligorsky MS; Fu BM
Am J Pathol; 2016 Feb; 186(2):248-58. PubMed ID: 26683662
[TBL] [Abstract][Full Text] [Related]
26. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx.
Chappell D; Jacob M; Hofmann-Kiefer K; Bruegger D; Rehm M; Conzen P; Welsch U; Becker BF
Anesthesiology; 2007 Nov; 107(5):776-84. PubMed ID: 18073553
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential.
Becker BF; Chappell D; Bruegger D; Annecke T; Jacob M
Cardiovasc Res; 2010 Jul; 87(2):300-10. PubMed ID: 20462866
[TBL] [Abstract][Full Text] [Related]
28. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions.
Okada H; Takemura G; Suzuki K; Oda K; Takada C; Hotta Y; Miyazaki N; Tsujimoto A; Muraki I; Ando Y; Zaikokuji R; Matsumoto A; Kitagaki H; Tamaoki Y; Usui T; Doi T; Yoshida T; Yoshida S; Ushikoshi H; Toyoda I; Ogura S
Crit Care; 2017 Oct; 21(1):261. PubMed ID: 29058634
[TBL] [Abstract][Full Text] [Related]
29. The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy.
Korakas E; Ikonomidis I; Markakis K; Raptis A; Dimitriadis G; Lambadiari V
Curr Vasc Pharmacol; 2020; 18(6):619-631. PubMed ID: 31889495
[TBL] [Abstract][Full Text] [Related]
30. A microscopic view on the renal endothelial glycocalyx.
Dane MJ; van den Berg BM; Lee DH; Boels MG; Tiemeier GL; Avramut MC; van Zonneveld AJ; van der Vlag J; Vink H; Rabelink TJ
Am J Physiol Renal Physiol; 2015 May; 308(9):F956-66. PubMed ID: 25673809
[TBL] [Abstract][Full Text] [Related]
31. Normal endothelium.
Pries AR; Kuebler WM
Handb Exp Pharmacol; 2006; (176 Pt 1):1-40. PubMed ID: 16999215
[TBL] [Abstract][Full Text] [Related]
32. [Expedition glycocalyx. A newly discovered "Great Barrier Reef"].
Chappell D; Jacob M; Becker BF; Hofmann-Kiefer K; Conzen P; Rehm M
Anaesthesist; 2008 Oct; 57(10):959-69. PubMed ID: 18810367
[TBL] [Abstract][Full Text] [Related]
33. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.
Becker BF; Jacob M; Leipert S; Salmon AH; Chappell D
Br J Clin Pharmacol; 2015 Sep; 80(3):389-402. PubMed ID: 25778676
[TBL] [Abstract][Full Text] [Related]
34. Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects.
Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
Int Angiol; 2014 Jun; 33(3):243-54. PubMed ID: 24936533
[TBL] [Abstract][Full Text] [Related]
35. Microvascular fluid exchange and the revised Starling principle.
Levick JR; Michel CC
Cardiovasc Res; 2010 Jul; 87(2):198-210. PubMed ID: 20200043
[TBL] [Abstract][Full Text] [Related]
36. Damage of the endothelial glycocalyx in chronic kidney disease.
Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
[TBL] [Abstract][Full Text] [Related]
37. An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation.
Brucker WJ; Croteau SE; Prensner JR; Cullion K; Heeney MM; Lo J; McAlvin JB; Peeler K; Shah N; Yee CSK; Berry GT; Bodamer O
J Inherit Metab Dis; 2020 Jul; 43(4):880-890. PubMed ID: 32064623
[TBL] [Abstract][Full Text] [Related]
38. [Glycocalyx and fluid therapy].
Ahonen J
Duodecim; 2015; 131(20):1937-46. PubMed ID: 26638348
[TBL] [Abstract][Full Text] [Related]
39. Targeting Endothelial Dysfunction in Acute Critical Illness to Reduce Organ Failure.
Juffermans NP; van den Brom CE; Kleinveld DJB
Anesth Analg; 2020 Dec; 131(6):1708-1720. PubMed ID: 33186159
[TBL] [Abstract][Full Text] [Related]
40. The Pathological Relevance of Increased Endothelial Glycocalyx Permeability.
Butler MJ; Down CJ; Foster RR; Satchell SC
Am J Pathol; 2020 Apr; 190(4):742-751. PubMed ID: 32035881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
